Furthermore, LIQ exerts its antitumor potential by inhibiting several signaling pathways, such as NF-κB, PI3K/Akt/mTOR, MAPK, JNK, and their associated proteins, which play crucial roles in cancer progression. Here, NFKB1 is linked to cancer.